Kaboli et al. (2020) concluded that SFN reduces NF-κB activity, downregulates apoptosis inhibitors, decreases the activity of histone deacetylases leading to cell cycle arrest, as well as increases the sensitivity of BC cells to chemotherapy [113]. Here, NFKB1 is linked to breast cancer.